Feb 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2022 Dec 31, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.74 9.56 12.01
(-8.6 pct) (-7.0 pct)
Operating loss 767 mln loss 505 mln loss 680 mln
Recurring loss 742 mln loss 480 mln loss 650 mln
Net loss 810 mln loss 529 mln loss 750 mln
EPS loss 214.40 yen loss 139.98 yen loss 198.33 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T